Shell Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
|
|||||
|
2025
Q1 | $296K | Sell |
|
|||||
|
2024
Q4 | $338K | Hold |
|
|||||
|
2024
Q3 | $291K | Buy |
|
|||||
|
2024
Q1 | $264K | Sell |
|
|||||
|
2023
Q4 | $314K | Sell |
|
|||||
|
2023
Q3 | $390K | Sell |
|
|||||
|
2023
Q2 | $433K | Sell |
|
|||||
|
2023
Q1 | $524K | Sell |
|
|||||
|
2022
Q4 | $518K | Sell |
|
|||||
|
2022
Q3 | $597K | Sell |
|
|||||
|
2022
Q2 | $643K | Buy |
|
|||||
|
2022
Q1 | $717K | Sell |
|
|||||
|
2021
Q4 | $743K | Buy |
|
|||||
|
2021
Q3 | $676K | Sell |
|
|||||
|
2021
Q2 | $814K | Buy |
|
|||||
|
2021
Q1 | $655K | Buy |
|
|||||
|
2020
Q4 | $509K | Hold |
|
|||||
|
2020
Q3 | $422K | Buy |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.01M | Sell |
|
|||||
|
2019
Q1 | $1.09M | Hold |
|
|||||
|
2018
Q4 | $1.03M | Sell |
|
|||||
|
2018
Q3 | $1.7M | Sell |
|
|||||
|
2018
Q2 | $2.82M | Sell |
|
|||||
|
2018
Q1 | $2.28M | Hold |
|
|||||
|
2017
Q4 | $1.98M | Hold |
|
|||||
|
2017
Q3 | $1.99M | Sell |
|
|||||
|
2017
Q2 | $2.19M | Hold |
|
|||||
|
2017
Q1 | $1.59M | Sell |
|
|||||
|
2016
Q4 | $1.37M | Sell |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.17M | Buy |
|